Allergy and Immunology
Showing page 9 of 24 pages of list content
-
Evaluation of Commercial Anti-SARS-CoV-2 Neutralizing Antibody Assays in seropositive subjects
This article's authors -
Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2
This article's authors -
Preserved recognition of Omicron Spike following COVID-19 mRNA vaccination in pregnancy
This article's authors -
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
This article's authors -
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose
This article's authors -
Prediction of SARS-CoV-2 Omicron Variant Immunogenicity, Immune Escape and Pathogenicity, through Analysis of Spike Protein-specific Core Unique Peptides
This article's authors -
A magnetic bead immunoassay to detect human IgG reactive to SARS-CoV-2 Spike S1 RBD produced in Escherichia coli
This article's authors -
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
This article's authors -
Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients
This article's authors -
Anti-SARS-CoV-2 cellular immunity in 571 vaccinees assessed using an interferon-γ release assay
This article's authors